Anti-FOLC/ FPGS functional antibody

Anti-FOLC/ FPGS functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to FPGS/FPGS products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1505-Ab-1/ GM-Tg-hg-SE1505-Ab-2Anti-Human FPGS monoclonal antibodyHuman
GM-Tg-rg-SE1505-Ab-1/ GM-Tg-rg-SE1505-Ab-2Anti-Rat FPGS monoclonal antibodyRat
GM-Tg-mg-SE1505-Ab-1/ GM-Tg-mg-SE1505-Ab-2Anti-Mouse FPGS monoclonal antibodyMouse
GM-Tg-cynog-SE1505-Ab-1/ GM-Tg-cynog-SE1505-Ab-2Anti-Cynomolgus/ Rhesus macaque FPGS monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1505-Ab-1/ GM-Tg-felg-SE1505-Ab-2Anti-Feline FPGS monoclonal antibodyFeline
GM-Tg-cang-SE1505-Ab-1/ GM-Tg-cang-SE1505-Ab-2Anti-Canine FPGS monoclonal antibodyCanine
GM-Tg-bovg-SE1505-Ab-1/ GM-Tg-bovg-SE1505-Ab-2Anti-Bovine FPGS monoclonal antibodyBovine
GM-Tg-equg-SE1505-Ab-1/ GM-Tg-equg-SE1505-Ab-2Anti-Equine FPGS monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1505-Ab-1/ GM-Tg-hg-SE1505-Ab-2; GM-Tg-rg-SE1505-Ab-1/ GM-Tg-rg-SE1505-Ab-2;
GM-Tg-mg-SE1505-Ab-1/ GM-Tg-mg-SE1505-Ab-2; GM-Tg-cynog-SE1505-Ab-1/ GM-Tg-cynog-SE1505-Ab-2;
GM-Tg-felg-SE1505-Ab-1/ GM-Tg-felg-SE1505-Ab-2; GM-Tg-cang-SE1505-Ab-1/ GM-Tg-cang-SE1505-Ab-2;
GM-Tg-bovg-SE1505-Ab-1/ GM-Tg-bovg-SE1505-Ab-2; GM-Tg-equg-SE1505-Ab-1/ GM-Tg-equg-SE1505-Ab-2
Products NameAnti-FPGS monoclonal antibody
Formatmab
Target NameFPGS
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FPGS benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1505-Ag-1Recombinant multi-species FOLC/ FPGS protein
    ORF Viral VectorpGMLPm004990mouse Fpgs Lentivirus plasmid
    ORF Viral VectorvGMLPm004990mouse Fpgs Lentivirus particle


    Target information

    Target IDGM-SE1505
    Target NameFPGS
    Gene ID2356,14287,687266,699587,100855785,101092966,505809,100070426
    Gene Symbol and SynonymsFPGS
    Uniprot AccessionQ05932,A6H751
    Uniprot Entry NameFOLC_HUMAN,FOLC_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseCancer
    Gene EnsemblENSG00000136877
    Target ClassificationTumor-associated antigen (TAA)

    The target: FPGS, gene name: FPGS, also named as . This gene encodes the folylpolyglutamate synthetase enzyme. This enzyme has a central role in establishing and maintaining both cytosolic and mitochondrial folylpolyglutamate concentrations and, therefore, is essential for folate homeostasis and the survival of proliferating cells. This enzyme catalyzes the ATP-dependent addition of glutamate moieties to folate and folate derivatives. Alternative splicing results in transcript variants encoding different isoforms. [provided by RefSeq, Jan 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.